Immun’Âge® Granted Japanese Patent Recognizing Activation of Nrf2, the Body’s Master ...

Backed by more than 30 peer-reviewed human clinical studies supporting endogenous antioxidant activity, cellular ...
EurekAlert!

Novel therapeutic strategy: Nrf2 activation in targeting senescence-related changes in ...

• Activation of nuclear factor erythroid 2-related factor 2 (Nrf2) significantly reduces the accumulation of senescent bronchial epithelial cells in chronic obstructive pulmonary disease (COPD) models ...
Palladium-Item

Immun’Âge® Granted Japanese Patent Recognizing Activation of Nrf2, the Body’s Master ...

LOS ANGELES, CA, UNITED STATES, January 27, 2026 /EINPresswire.com/ — Osato Research Institute today announced that Immun’Âge ®, a fermented papaya preparation ...
Nasdaq

LifeVantage® Study Reveals Synergistic Effects of Protandim® Nrf2 Synergizer® and ...

SALT LAKE CITY, Nov. 29, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes, today ...